iSpecimen Completes $1.75 Million Private Placement

August 8, 2025 — Leads & Copy — WOBURN, Mass. — iSpecimen Inc. closed a private placement with accredited investors for gross proceeds of about $1.75 million. The company intends to use $500,000 of the net proceeds for marketing and advertising services provided by IR Agency LLC and the remainder for working capital.

In connection with the offering, iSpecimen issued 1,559,828 shares of common stock (or pre-funded warrants) at $1.122 per share.

WestPark Capital, Inc. was the exclusive placement agent.

Additional details are available in a Form 8-K filed with the SEC.

The securities have not been registered under the Securities Act of 1933 and may not be offered or sold in the U.S. absent registration with the SEC or an applicable exemption.

Contact:
info@ispecimen.com

Source: iSpecimen

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.